HOME >> MEDICINE >> NEWS
New bedside tool gauges mortality risk in heart failure patients

For the first time, UCLA researchers have developed a new evaluation tool that can predict mortality risk in patients hospitalized with heart failure. The new tool -- used right at the bedside -- will help clinicians quickly decide upon hospital admission which patients are at a greater mortality risk that may require higher monitoring and earlier, more intensive intervention.

Published in the February 2, 2005 edition of JAMA, the new tool utilizes the combination of three simple measures obtained through laboratory blood tests and by measuring vital signs. Heart failure is a condition that affects five million Americans and is the leading cause of hospitalization for those over age 65.

"The new tool is a first for the treatment of acute heart failure, and offers a simple quick way for clinicians to assess mortality risk upon hospital admission and quickly decide on a treatment strategy," said Dr. Gregg C. Fonarow, lead study author, The Eliot Corday Chair in Cardiovascular Medicine and Science, professor of cardiology, David Geffen School of Medicine at UCLA and director, Ahmanson-UCLA Cardiomyopathy Center.

Using data from a national registry of over 100,000 heart failure patients called the Acute Decompensated Heart Failure National Registry (ADHERE), researchers developed a risk model after analyzing 33,046 hospitalizations. The model was developed using a relatively new statistical technique know as Classification and Regression Tree Analysis (CART). The validity of the model was then tested using data from an additional 32,229 hospitalizations.

Researchers evaluated 39 possible factors as survival indicators upon hospital admission and found that the best single predictor for mortality was a high blood urea nitrogen level, (above 43 mg/dL), followed by a low systolic blood pressure (above 115 mm Hg) and a high serum creatinine (higher than 2.75 mg/dL).

"This validated risk tree provides clinicians with a
'"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-2270
University of California - Los Angeles
1-Feb-2005


Page: 1 2 3

Related medicine news :

1. Teaching human side of patient care is best done at the bedside, say medical educators
2. Study gauges patient opinions in L.A. County
3. Study provides new estimates of the causes of child mortality worldwide
4. Even mild depression increases long-term mortality in heart failure
5. Inpatient smoking cessation counseling is associated with early differences in mortality
6. Heart failure patients treated for diabetes with insulin have increase in mortality
7. Model predicting colorectal cancer screening suggests higher mortality for virtual colonoscopy
8. UK universitys research throws light on early infant mortality
9. Major study: Bioartificial liver reduces mortality by 44 percent in acute liver-failure patients
10. Implantable cardiac defibrillator use significantly lowers heart failure mortality
11. Coronary aneurysms are independent predictor of mortality, should be aggressively monitored

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New bedside tool gauges mortality risk heart failure patients

(Date:5/20/2013)... The automated external defibrillator market is ... - semi-automated and fully automated defibrillators. Based on ... namely, hospitals, pre-hospital, public access, alternate care, and ... external defibrillators play an important role in saving ... the life-saving potential of AEDs, legislations requiring installation ...
(Date:5/20/2013)... May 20, 2013 Recent environmental ... of using green and sustainable inputs in packaging ... implemented regulations to promote the use of sustainable ... and Labelling Services industry . “Tax subsidies and ... says IBISWorld industry analyst Deonta Smith. “For example, ...
(Date:5/20/2013)... Florida (PRWEB) May 20, 2013 In order ... supplemental health and wellness team from DrSmartphoneMD launched an article ... serious sunburns. , The series launched with the ... that members of the DrSmartphoneMD program are not one of ... team explained that more than 90% of all skin cancer ...
(Date:5/20/2013)... 20, 2013 Parker Waichman LLP, a ... victims injured by defective drugs, has filed a lawsuit ... that use of the diabetes drug medication Actos ... on April 30, 2013, in the U.S. District Court ... where it is one of thousands of cases pending ...
(Date:5/20/2013)... May 20, 2013 Mirena IUD ... the multidistrict litigation recently established in U.S. District Court, ... According to court records, the litigation’s first Status ... appointments to Plaintiff’s leadership positions were discussed. So ... the Southern District of New York, all of which ...
Breaking Medicine News(10 mins):Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Combat Skin Cancer In Summer Months 2Health News:Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3
(Date:5/20/2013)... VIEJO , Kalifornien, 20. Mai 2013 ... bekannt, dass das Unternehmen die CE-Kennzeichnung für ... zur Embolisation von Aneurysmen erhalten hat. Das ... Europa bereits mit der kontrollierten Einführung dieser ... bietet die SL-Produktfamilie auch ein verbessertes Handling, ...
(Date:5/20/2013)... , BERLIN and ... Arthroscopy Devices Market to 2018 ... Invasive Procedures to Drive Future Growth" looks at the ... six arthroscopy device market segments: arthroscopes, arthroscopy shavers, arthroscopy ... systems, and arthroscopy visualization systems. The report provides comprehensive ...
(Date:5/20/2013)... Md. , May 20, 2013  Neuralstem, Inc. ... Feldman , MD, PhD, principal investigator, presented updated ... stem cell (NSI-566) trial in the treatment of amyotrophic ... ,s disease) at the neuro diabetes special medical symposium ... In a talk called "Recent Therapeutic Advances in Stem ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4
Cached News: